Regulatory Compliance

Columbia, Md. – September 29, 2026 -- The Maryland Stem Cell Research Commission has awarded more than $4.8 million through the Maryland Stem Cell Research Fund (MSCRF) in the first funding cycle of fiscal year 2027, backing 15 investigators across the state's regenerative medicine sector.

Applications for MSCRF funding continue to exceed available resources

Requested funding significantly outstripped the capital available for this cycle, according to the Commission, reflecting both the depth of Maryland's research base and a rising number of technologies advancing past early discovery into validation, clinical development and manufacturing—stages that require substantially more capital.

Charleston, W.Va. – September 29, 2026 -- West Virginia American Water has rolled out FlowCam flow-imaging technology to rapidly detect algae and cyanobacteria in source-water samples, part of a broader push during American Water Works Association's Source Water Protection Week (September 27 to October 3) to reduce contamination risks and treatment costs across its supply network.

The utility, a subsidiary of American Water (NYSE: AWK), serves approximately 610,000 people in the state and employs around 315 people.

FlowCam imaging enables earlier detection of biological changes in water supplies

The flow-imaging system captures high-resolution images of algae and cyanobacteria, allowing faster organism classification and enumeration. This supports quicker treatment decisions before contamination escalates.

Beijing – September 29, 2026 -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) will cut its outstanding Class A share count from 145,814,975 to approximately 7,290,749 through a 20-to-1 reverse share consolidation, with post-combination trading starting October 2, 2026.

Board approves reverse split to lift share price above Nasdaq minimum

ReTo's board approved the combination to raise the market price per Class A share, a move the company states is intended to help it maintain its Nasdaq Capital Market listing. The shares will keep trading under the ticker "RETO" but will carry a new CUSIP number, G75271158.

No par value changes, no shareholder vote required

The par value of the Class A Shares remains unaffected by the consolidation. Because ReTo is incorporated in the British Virgin Islands, the transaction does not require shareholder approval and will proceed automatically without any action from holders.

Milwaukee – September 29, 2026 -- PBS Biotech has embedded Rockwell Automation technology into its MiniPRO multi-parallel bioreactor platform, a system with up to 24 independently controlled bioreactors designed to speed cell therapy process development and reduce risk during scale-up to commercial manufacturing.

Platform integrates FactoryTalk software with PlantPAx distributed control

The MiniPRO uses Rockwell's FactoryTalk software and Process Library to deliver real-time process control within an automation environment that can integrate directly into a larger PlantPAx distributed control system used to run an entire cell-therapy facility. Rockwell Automation, headquartered in Milwaukee and employing roughly 26,000 people across more than 100 countries as of fiscal year 2025, positions the collaboration as a way to standardize automation across development and GMP manufacturing stages.

Greenlawn, N.Y. – September 29, 2026 -- BAE Systems has secured AIMS certification from the Department of War for its new AN/APX-127(V)1 Combined Interrogator Transponder (CIT), clearing the Identification Friend or Foe (IFF) system for use on the U.S. Air Force's F-16 Fighting Falcon fleet.

Certification confirms interoperability across U.S. and NATO forces

The AIMS standard verifies the system meets joint U.S. and NATO requirements, allowing pilots to distinguish allied aircraft from potential threats in contested airspace. The AN/APX-127(V)1 is AIMS Mark XIIB IFF certified with Mode S and Mode 5 capability for encrypted data exchange, and adds receive channels for passive acquisition of Mode 5 Level 2 and Automatic Dependent Surveillance – Broadcast In signals.

New York City – – September 29, 2026 -- Demy-Colton has released the agenda for BioFuture 2026, a two-day conference set for October 27–28 at Cure, 345 Park Avenue South, drawing more than 100 speakers and over 50 presenting companies from biopharma, investment, technology and policy sectors.

Conference agenda spans AI, oncology, biotech financing and global drug development

Speakers include representatives from Johnson & Johnson, Regeneron Pharmaceuticals, Schrödinger, Piper Sandler and Mizuho Securities. Sponsors backing the event include Regeneron Pharmaceuticals, Russo Partners, WuXi AppTec, Blue Matter, Cure, Evotec, Ipsen, Thermo Fisher Scientific, Big4Bio, HMA Consulting, Withum and Hogan Lovells Cadwalader.

Calgary, AB – – September 29, 2026 -- Canadian oil sands production is projected to average a record 3.5 million barrels per day (b/d) in 2026, a 100,000 b/d increase of 3% over the prior year, according to S&P Global Energy's latest 10-year production outlook. Output is forecast to climb further to 3.9 million b/d by the early 2030s.

Production has grown almost every year since 2001, when output stood at just 300,000 b/d

The only exception was 2020, when COVID-19 disrupted demand. Most of the 2026 gains stem from optimization of existing facilities rather than new construction, S&P Global Energy said.

Dallas – September 29, 2026 -- The global rare earth magnets market is projected to grow from roughly $21.98 billion in 2025 to $30.01 billion by 2030, a 6.4% compound annual growth rate, according to ResearchAndMarkets.com, with electric vehicles, wind turbines, robotics and consumer electronics driving demand. Persistence Market Research puts the 2026 market at $15.8 billion, rising to $30.4 billion by 2033 at a 9.8% CAGR, and identifies North America as the fastest-growing region at 11.3% annually. Texas is emerging as the geographic center of that domestic build-out.

Campbell, Calif. – September 29, 2026 -- Vivalink, a digital healthcare solutions provider, published survey data showing 79% of more than 150 U.S. adults with cardiac conditions would participate in a home-based cardiac rehabilitation program if recommended by a provider.

Patients favor hybrid or home-based rehab over clinic visits

When given a choice, 68% of respondents said they would prefer a primarily home-based or hybrid rehabilitation approach over traditional in-clinic programs.

Insurance coverage ranks as the top barrier to participation

Fifty-eight percent of respondents ranked insurance coverage as their top consideration for participating in home-based care. Sixty percent said they would not pay out of pocket for such a program, while 87% said confirmed insurance coverage would increase their likelihood of participating.

Boston – September 29, 2026 -- Gryphon has released Gryphon ONE on the Genesys Cloud AppFoundry, a real-time compliance layer that lets enterprises recover 35%-45% of their contactable customer universe by preventing over-suppression in outbound dialing campaigns.

Gryphon ONE screens calls against TCPA, TSR and Do Not Call rules before dialing occurs

The integration evaluates automated outbound dialing against the Telephone Consumer Protection Act, the Telemarketing Sales Rule, Do Not Call registries and state-specific standards in real time. Enterprises using highly regulated data sets can now operationalize governance, risk and compliance directly within Genesys Cloud outbound workflows, removing manual handoffs between compliance teams and campaign launch.